News & Analysis as of

News from Abroad: EPO Clarifies Extent to which Methods Involving Use of Human Embryos Are Excluded from Patentability

Generally, the European Patent Office does not allow claims to methods involving the use of human embryos for industrial or commercial purposes. It was therefore perhaps not surprising that the Examiner objected to the...more

News from Abroad: Emerging Practice of the European Patent Office on Stem Cell Inventions

Originally published in Forresters on November 25, 2012. Is There Light at the End of the Tunnel? - It is clear from an emerging practice of the European Patent Office (EPO) that they were not widely impressed...more

News from Abroad: EPO Codifies CJEU's Decision on Human Embryonic Stem Cells

On 8 October 2011, the Court of Justice of the European Union's (CJEU) handed down a landmark judgment on the correct interpretation of Article 6(2)(c) of the Biotechnology Directive (98/44/EC) relating to the patentability...more

3 Results
|
View per page
Page: of 1